389
Participants
Start Date
June 29, 2023
Primary Completion Date
June 18, 2025
Study Completion Date
June 18, 2025
AKH Wien, Vienna
ICAHN School of Medicine at Mount Sinai,, New York
University Hospital Lübeck, Lübeck
Duke Cancer Institute - School of Medicine, Durham
Levine Cancer Institute, Charlotte
Chu Bordeaux Hopital Saint Andre, Bordeaux
Vanderbilt - Ingram Cancer Center, Nashville
Alexianer Krefeld GmbH, Krefeld
Avera Cancer Institute Center, Sioux Falls
Centre Léon Bérard, Lyon
CHU LYON, Pierre-Bénite
Stuttgart Hospital, Stuttgart
Institut Mutualiste Montsouris, Paris
CHU de Rouen., Rouen
University of Colorado Hospital, Aurora
Mayo Clinic, Phoenix
Centre Hospitalier Départemental Les Oudairies, La Roche-sur-Yon
University of California Los Angeles, Santa Monica
Foch Hospital, Suresnes
University of California Irvine, Orange
University of California San Francisco, San Francisco
Stanford Cancer Institute - School of Medicine, Palo Alto
Centre Antoine Lacassagne, Nice
Seagen, a wholly owned subsidiary of Pfizer
INDUSTRY